课题基金 / 基金详情

Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis

Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesis
结核分枝杆菌发病机制中的一氧化碳耐药性
批准号:
9113479
负责人:
MICHAEL SHILOH
金额:
$39.75万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-27 至 2018-08-31

项目摘要

项目成果

MICHAEL SHILOH的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):结核分枝杆菌仍然是最具破坏性的人类传染病之一,每年造成200万人死亡,潜在感染世界三分之一的人口。作为适应长期生存的细胞内病原体,结核分枝杆菌已经进化出抵抗宿主抗菌途径杀死的机制。针对这些耐药机制最近出现了一种强有力的新方法,通过增强宿主根除细菌的能力来治疗结核分枝杆菌感染。然而,分枝杆菌耐药基因的全部曲目尚不清楚,扩大这一知识库为开发新药提供了额外的途径。我们证明结核分枝杆菌诱导一种酶,血红素加氧酶,产生一氧化碳(CO)气体,结核分枝杆菌既适应又抵抗一氧化碳的杀伤。我们假设结核分枝杆菌进化出了CO抗性基因,我们的初步数据表明结核分枝杆菌编码了一个这样的基因,当突变时导致毒性减弱。我们将应用代谢组学、转录组学、蛋白质组学和生化方法来确定新发现的CO抗性蛋白的功能。因此,在本研究中,我们将(1)确定CO抗性的分子机制,(2)确定CO抗性基因的相互作用伙伴及其在CO抗性中的作用,(3)表征CO抗性基因及其相互作用伙伴突变体的致病作用。所提出的工作将扩展目前对结核分枝杆菌抗微生物药物耐药性机制的了解,并揭示一种新的微生物生存策略。
英文摘要
DESCRIPTION (provided by applicant): Mycobacterium tuberculosis remains one of the most devastating human infectious diseases, causing two million deaths annually and latently infecting a third of the world's population. As an intracellular pathogen adapted to long-term survival, M. tuberculosis has evolved mechanisms to resist killing by host antimicrobial pathways. Targeting those resistance mechanisms has recently emerged as a powerful new approach to treating M. tuberculosis infection by enhancing the host's ability to eradicate the bacteria. However, the full repertoire of mycobacterial resistance genes is not known, and expanding this knowledge base provides additional avenues for the development of new drugs. We demonstrated the M. tuberculosis induces an enzyme, heme oxygenase, that produces carbon monoxide (CO) gas, and that M. tuberculosis both adapts to and resists killing by CO. We hypothesized that M. tuberculosis evolved genes for CO resistance, and our preliminary data indicate that M. tuberculosis encodes one such gene that when mutated results in attenuated virulence. We will apply metabolomic, transcriptomic, proteomic, and biochemical approaches to determine the function of the newly discovered CO resistance protein. Thus, in the proposed research we will (1) identify the molecular mechanism of CO resistance, (2) determine the interacting partners of the CO resistance gene and their role in CO resistance and (3) characterize the pathogenic effects of mutants in the CO resistance gene and its interacting partners. The proposed work will extend the current knowledge on M. tuberculosis's antimicrobial resistance mechanisms and reveal a novel microbial survival strategy.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Mechanisms of cough in Mycobacterium tuberculosis transmission
  • 批准号:
    10368154
  • 项目类别:
  • 资助金额:
    $72.59万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL SHILOH
  • 依托单位:
Project 3: Mechanisms of cough in M. tuberculosis transmission
Mechanisms of cough in Mycobacterium tuberculosis transmission
  • 批准号:
    10578845
  • 项目类别:
  • 资助金额:
    $72.59万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL SHILOH
  • 依托单位:
Project 3: Mechanisms of cough in M. tuberculosis transmission
国内基金
海外基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
  • 批准号:
    22007039
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    王黎明
  • 依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
  • 批准号:
    21172061
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2011
  • 负责人:
    许新华
  • 依托单位: